- Home
- KLRS vs LXEH Comparison
KLRS vs LXEH Comparison
Compare KLRS & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- LXEH
- Stock Information
- Founded
- KLRS 2019
- LXEH 2001
- Country
- KLRS United States
- LXEH China
- Employees
- KLRS N/A
- LXEH N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- LXEH Other Consumer Services
- Sector
- KLRS Health Care
- LXEH Real Estate
- Exchange
- KLRS Nasdaq
- LXEH Nasdaq
- Market Cap
- KLRS 46.0M
- LXEH 55.2M
- IPO Year
- KLRS N/A
- LXEH 2020
- Fundamental
- Price
- KLRS $6.62
- LXEH $0.65
- Analyst Decision
- KLRS Strong Buy
- LXEH
- Analyst Count
- KLRS 2
- LXEH 0
- Target Price
- KLRS $23.00
- LXEH N/A
- AVG Volume (30 Days)
- KLRS 232.2K
- LXEH 4.4M
- Earning Date
- KLRS 11-15-2025
- LXEH 09-26-2025
- Dividend Yield
- KLRS N/A
- LXEH N/A
- EPS Growth
- KLRS N/A
- LXEH N/A
- EPS
- KLRS N/A
- LXEH N/A
- Revenue
- KLRS N/A
- LXEH $4,493,795.00
- Revenue This Year
- KLRS N/A
- LXEH N/A
- Revenue Next Year
- KLRS N/A
- LXEH N/A
- P/E Ratio
- KLRS N/A
- LXEH N/A
- Revenue Growth
- KLRS N/A
- LXEH N/A
- 52 Week Low
- KLRS $2.14
- LXEH $0.51
- 52 Week High
- KLRS $24.15
- LXEH $50.08
- Technical
- Relative Strength Index (RSI)
- KLRS 59.56
- LXEH 24.03
- Support Level
- KLRS $6.50
- LXEH $0.57
- Resistance Level
- KLRS $8.80
- LXEH $3.28
- Average True Range (ATR)
- KLRS 0.95
- LXEH 0.38
- MACD
- KLRS 0.09
- LXEH -0.32
- Stochastic Oscillator
- KLRS 51.25
- LXEH 5.61
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.